Standard Biotools | FLDM - Sales Revenues


Standard Biotools reported $21.1M in Sales Revenues for its fiscal quarter ending in March of 2026.





Sales Change Date
Agilent USD 1.84B 37M Mar/2026
Becton, Dickinson and Co. USD 4.7B 600M Mar/2026
Bio-Rad Laboratories USD 592.1M 101.1M Mar/2026
Bruker USD 823.4M 153.8M Mar/2026
Danaher USD 5.95B 890M Mar/2026
Illumina USD 1.09B 70M Mar/2026
Myriad Genetics USD 200.4M 9.4M Mar/2026
Nikon Corporation JPY 193.26B 22.27B Mar/2026
Pacific Biosciences Of California USD 44.64M 6.2M Dec/2025
Revvity USD 711M 61.06M Mar/2026
Roche Holding CHF 15.65B 274.5M Dec/2025
Sony JPY 3.04T 670B Mar/2026
Standard Biotools USD 21.1M 2.7M Mar/2026
Thermo Fisher Scientific USD 11.01B 1.2B Mar/2026
Waters USD 1.27B 338M Mar/2026